Predicted to enable NADPH binding activity and NADPH-adrenodoxin reductase activity. Predicted to be involved in NADPH oxidation and ubiquinone biosynthetic process. Predicted to act upstream of or within cholesterol metabolic process. Located in mitochondrial inner membrane. Orthologous to human FDXR (ferredoxin reductase). [provided by Alliance of Genome Resources, Apr 2022]